Massimo Dominici
Massimo Dominici
Department of Medical and Surgical Science, University of Modena and Reggio Emilia, Italy
Email verificata su - Home page
TitoloCitata daAnno
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M Dominici, K Le Blanc, I Mueller, I Slaper-Cortenbach, FC Marini, ...
Cytotherapy 8 (4), 315-317, 2006
Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement
EM Horwitz, K Le Blanc, M Dominici, I Mueller, I Slaper-Cortenbach, ...
Cytotherapy 7 (5), 393-395, 2005
Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International …
P Bourin, BA Bunnell, L Casteilla, M Dominici, AJ Katz, KL March, H Redl, ...
Cytotherapy 15 (6), 641-648, 2013
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the …
C Théry, KW Witwer, E Aikawa, MJ Alcaraz, JD Anderson, ...
Journal of extracellular vesicles 7 (1), 1535750, 2018
Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs
C Martinez, TJ Hofmann, R Marino, M Dominici, EM Horwitz
Blood 109 (10), 4245-4248, 2007
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM
I Müller, S Kordowich, C Holzwarth, C Spano, G Isensee, A Staiber, ...
Cytotherapy 8 (5), 437-444, 2006
International Society for Cellular Therapy. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement
EM Horwitz, K Le Blanc, M Dominici, I Mueller, I Slaper-Cortenbach, ...
Cytotherapy 7 (5), 393-395, 2005
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor–related apoptosis-inducing ligand delivery for cancer therapy
G Grisendi, R Bussolari, L Cafarelli, I Petak, V Rasini, E Veronesi, ...
Cancer research 70 (9), 3718-3729, 2010
Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells
F Gieseke, J Böhringer, R Bussolari, M Dominici, R Handgretinger, ...
Blood 116 (19), 3770-3779, 2010
Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation
I Müller, S Kordowich, C Holzwarth, G Isensee, P Lang, F Neunhoeffer, ...
Blood Cells, Molecules, and Diseases 40 (1), 25-32, 2008
Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation
M Dominici, C Pritchard, JE Garlits, TJ Hofmann, DA Persons, EM Horwitz
Proceedings of the National Academy of Sciences 101 (32), 11761-11766, 2004
Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation
M Dominici, V Rasini, R Bussolari, X Chen, TJ Hofmann, C Spano, ...
Blood 114 (11), 2333-2343, 2009
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials
J Galipeau, M Krampera, J Barrett, F Dazzi, RJ Deans, J DeBruijn, ...
Cytotherapy 18 (2), 151-159, 2016
How do mesenchymal stromal cells exert their therapeutic benefit?
EM Horwitz, M Dominici
Cytotherapy 10 (8), 771-774, 2008
Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table
O Parolini, F Alviano, I Bergwerf, D Boraschi, C De Bari, P De Waele, ...
Stem cells and development 19 (2), 143-154, 2010
Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase
K Mihara, C Imai, E Coustan‐Smith, JS Dome, M Dominici, E Vanin, ...
British journal of haematology 120 (5), 846-849, 2003
Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms
S Otsuru, PL Gordon, K Shimono, R Jethva, R Marino, CL Phillips, ...
Blood 120 (9), 1933-1941, 2012
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-institution analysis
MV Dieci, E Barbieri, F Piacentini, G Ficarra, S Bettelli, M Dominici, ...
Annals of oncology 24 (1), 101-108, 2012
Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning
TS Olson, A Caselli, S Otsuru, TJ Hofmann, R Williams, P Paolucci, ...
Blood 121 (26), 5238-5249, 2013
Mesenchymal stromal/stem cells markers in the human bone marrow
V Rasini, M Dominici, T Kluba, G Siegel, G Lusenti, H Northoff, ...
Cytotherapy 15 (3), 292-306, 2013
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20